Mylan not relying on acquisitions if Perrigo bid fails -chairman

TEL AVIV, Nov 4 (Reuters) - Mylan will likely win its bid to take over Irish-based generic drugmaker Perrigo Co , but if the bid fails the company can live without seeking an alternative acquisition, its chairman said on Wednesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.